{
    "data": {
        "drugs": {
            "nodes": [
                {
                    "interactions": [
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                },
                                {
                                    "name": "Direct Interaction",
                                    "value": "true"
                                },
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Platelet-derived growth factor receptor beta inhibitor"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PDGFRB",
                                "longName": "platelet derived growth factor receptor beta",
                                "conceptId": "hgnc:8804",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.09177883009649355,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "ChEMBL"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "FDA"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "OncoKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TALC"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Pond D et al., 2018, A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib., Genet Med",
                                            "pmid": 28726812
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TTD"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA::wildtype:."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA:D842V"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA:T674I"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA__."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA__FIP1L1"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA::consequence::inframe_deletion:I843."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA:552-596,631-668,814-854"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PDGFRA:P577S,R841K,H845Y,G853D"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "late trials, preclinical"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "preclinical"
                                },
                                {
                                    "name": "Pathway",
                                    "value": "activation"
                                },
                                {
                                    "name": "Variant Effect",
                                    "value": "gain-of-function"
                                },
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                },
                                {
                                    "name": "Fusion Protein",
                                    "value": "FIP1L1:PDGFRA"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PDGFRA",
                                "longName": "platelet derived growth factor receptor alpha",
                                "conceptId": "hgnc:8803",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"
                                    }
                                ]
                            },
                            "interactionScore": 0.2733805480087357,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Dai J et al., 2013, Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib., Clin Cancer Res",
                                            "pmid": 24132921
                                        },
                                        {
                                            "citation": "Yoo C et al., 2016, Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors., Cancer Res Treat",
                                            "pmid": 26130666
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2012, Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors., Clin Cancer Res",
                                            "pmid": 22745105
                                        },
                                        {
                                            "citation": "Corless CL et al., 2005, PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib., J Clin Oncol",
                                            "pmid": 15928335
                                        },
                                        {
                                            "citation": "Prenen H et al., 2006, Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate., Clin Cancer Res",
                                            "pmid": 16638875
                                        },
                                        {
                                            "citation": "Cassier PA et al., 2012, Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era., Clin Cancer Res",
                                            "pmid": 22718859
                                        },
                                        {
                                            "citation": "Hirota S et al., 2003, Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors., Gastroenterology",
                                            "pmid": 12949711
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2006, Molecular correlates of imatinib resistance in gastrointestinal stromal tumors., J Clin Oncol",
                                            "pmid": 16954519
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2003, Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor., J Clin Oncol",
                                            "pmid": 14645423
                                        },
                                        {
                                            "citation": "Lasota J et al., 2004, A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential., Lab Invest",
                                            "pmid": 15146165
                                        },
                                        {
                                            "citation": "MacConaill LE et al., 2014, Prospective enterprise-level molecular genotyping of a cohort of cancer patients., J Mol Diagn",
                                            "pmid": 25157968
                                        },
                                        {
                                            "citation": "Debiec-Rychter M et al., 2005, Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants., Gastroenterology",
                                            "pmid": 15685537
                                        },
                                        {
                                            "citation": "Dewaele B et al., 2008, Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation., Clin Cancer Res",
                                            "pmid": 18794084
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DoCM"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "FDA"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "OncoKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "COSMIC"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Heinrich MC et al., 2008, Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor., J Clin Oncol",
                                            "pmid": 18955458
                                        },
                                        {
                                            "citation": "Prenen H et al., 2006, Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate., Clin Cancer Res",
                                            "pmid": 16638875
                                        },
                                        {
                                            "citation": "Cassier PA et al., 2012, Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era., Clin Cancer Res",
                                            "pmid": 22718859
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2003, Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor., J Clin Oncol",
                                            "pmid": 14645423
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CYP2B6",
                                "longName": "cytochrome P450 family 2 subfamily B member 6",
                                "conceptId": "hgnc:2615",
                                "geneCategories": [
                                    {
                                        "name": "CYTOCHROME P450"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.02265789868007184,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Kassogue Y et al., 2014, Functional polymorphism of CYP2B6 G15631T is associated with hematologic and cytogenetic response in chronic myeloid leukemia patients treated with imatinib., Med Oncol",
                                            "pmid": 24293093
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "SLC19A1",
                                "longName": "solute carrier family 19 member 1",
                                "conceptId": "hgnc:10937",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    },
                                    {
                                        "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"
                                    }
                                ]
                            },
                            "interactionScore": 0.08056141752914434,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ravegnini G et al., 2019, An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor., Pharmacogenomics J",
                                            "pmid": 30237583
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CLK4",
                                "longName": "CDC like kinase 4",
                                "conceptId": "hgnc:13659",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.01479699505637345,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "NF1:."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "NF1:del"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "NF1",
                                "longName": "neurofibromin 1",
                                "conceptId": "hgnc:7765",
                                "geneCategories": [
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.03152403294618691,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "ABL1__BCR"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "ABL1:I242T,M244V,K247R,L248V,G250E,G250R,Q252R,Q252H,Y253F,Y253H,E255K,E255V,M237V,E258D,W261L,L273M,E275K,E275Q,D276G,T277A,E279K,V280A,V289A,V289I,E292V,E292Q,I293V,L298V,V299L,F311L,F311I,T315I,F317L,F317V,F317I,F317C,Y320C,L324Q,Y342H,M343T,A344V,A350V,M351T,E355D,E355G,E355A,F359V,F359I,F359C,F359L,D363Y,L364I,A365V,A366G,L370P,V371A,E373K,V379I,A380T,F382L,L384M,L387M,L387F,L387V,M388L,Y393C,H396P,H396R,H396A,A397P,S417F,S417Y,I418S,I418V,A433T,S438C,E450K,E450G,E450A,E450V,E453K,E453G,E453A,E453V,E459K,E459G,E459A,E459V,M472I,P480L,F486S,E507G"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Trametinib;Imatinib"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PRKCH:amp;ABL1__BCR"
                                },
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                },
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Inhibition"
                                },
                                {
                                    "name": "Endogenous Drug",
                                    "value": "false"
                                },
                                {
                                    "name": "Direct Interaction",
                                    "value": "true"
                                },
                                {
                                    "name": "Indication",
                                    "value": "lung adenocarcinoma"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "resistant"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Cell line xenograft"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "sensitive"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical"
                                },
                                {
                                    "name": "Indication",
                                    "value": "myeloid neoplasm"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Guideline"
                                },
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Tyrosine-protein kinase ABL inhibitor"
                                },
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Bcr/Abl fusion protein"
                                },
                                {
                                    "name": "Fusion Protein",
                                    "value": "BCR:ABL1"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABL1",
                                "longName": "ABL proto-oncogene 1, non-receptor tyrosine kinase",
                                "conceptId": "hgnc:76",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "TUMOR SUPPRESSOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.1115465781172767,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "ChEMBL"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Mojzych M et al., 2014, Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines., Eur J Med Chem",
                                            "pmid": 24681986
                                        },
                                        {
                                            "citation": "Page BD et al., 2012, Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity., J Med Chem",
                                            "pmid": 22148584
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "FDA"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "MyCancerGenome"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Schmandt RE et al., 2003, Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium., Cancer",
                                            "pmid": 12910520
                                        },
                                        {
                                            "citation": "Haberler C et al., 2006, Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy., J Neurooncol",
                                            "pmid": 16205964
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "OncoKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TALC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TTD"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TTD"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "GuideToPharmacology"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Ivan D et al., 2006, Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec)., J Cutan Pathol",
                                            "pmid": 16630177
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Testoni E et al., 2016, Somatically mutated ABL1 is an actionable and essential NSCLC survival gene., EMBO Mol Med",
                                            "pmid": 26758680
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "COSMIC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Indication",
                                    "value": "desmoid tumor"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "sensitive"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Clinical Study - Cohort"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CTNNB1",
                                "longName": "catenin beta 1",
                                "conceptId": "hgnc:2514",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR COMPLEX"
                                    }
                                ]
                            },
                            "interactionScore": 0.02197129568976663,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Kasper B et al., 2016, Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01)., Ann Surg Oncol",
                                            "pmid": 26861905
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "NTRK1",
                                "longName": "neurotrophic receptor tyrosine kinase 1",
                                "conceptId": "hgnc:8031",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    }
                                ]
                            },
                            "interactionScore": 0.02042402134541687,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "UGT2A1",
                                "longName": "UDP glucuronosyltransferase family 2 member A1 complex locus",
                                "conceptId": "hgnc:12542",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 1.450105515524598,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ravegnini G et al., 2019, An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor., Pharmacogenomics J",
                                            "pmid": 30237583
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "NQO2",
                                "longName": "N-ribosyldihydronicotinamide:quinone dehydrogenase 2",
                                "conceptId": "hgnc:7856",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.08530032444262341,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Michaelis S et al., 2012, Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2)., J Med Chem",
                                            "pmid": 22494098
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Fusion Protein",
                                    "value": "BCR:ABL1"
                                },
                                {
                                    "name": "Direct Interaction",
                                    "value": "true"
                                },
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Bcr/Abl fusion protein"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "BCR",
                                "longName": "BCR activator of RhoGEF and GTPase",
                                "conceptId": "hgnc:1014",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "TUMOR SUPPRESSOR"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.2306986047425497,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "ChEMBL"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TALC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "FDA"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Mojzych M et al., 2014, Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines., Eur J Med Chem",
                                            "pmid": 24681986
                                        },
                                        {
                                            "citation": "Page BD et al., 2012, Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity., J Med Chem",
                                            "pmid": 22148584
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "XIAP",
                                "longName": "X-linked inhibitor of apoptosis",
                                "conceptId": "hgnc:592",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "PROTEASE INHIBITOR"
                                    },
                                    {
                                        "name": "TUMOR SUPPRESSOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.03452632179820471,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Nimmanapalli R et al., 2001, Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells., Clin Cancer Res",
                                            "pmid": 11234890
                                        },
                                        {
                                            "citation": "Porosnicu M et al., 2001, Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells., Leukemia",
                                            "pmid": 11368438
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CYP3A5",
                                "longName": "cytochrome P450 family 3 subfamily A member 5",
                                "conceptId": "hgnc:2638",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "CYTOCHROME P450"
                                    }
                                ]
                            },
                            "interactionScore": 0.03222456701165773,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Harivenkatesh N et al., 2017, Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia., Pharmacol Res",
                                            "pmid": 28330783
                                        },
                                        {
                                            "citation": "Adeagbo BA et al., 2016, Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia., J Clin Pharm Ther",
                                            "pmid": 27426203
                                        },
                                        {
                                            "citation": "Cargnin S et al., 2018, Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis., Pharmacol Res",
                                            "pmid": 29427770
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ATIC",
                                "longName": "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase",
                                "conceptId": "hgnc:794",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.2900211031049196,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Cereja Pantoja KBC et al., 2022, Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia., Genes (Basel)",
                                            "pmid": 35205374
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "DDR1",
                                "longName": "discoidin domain receptor tyrosine kinase 1",
                                "conceptId": "hgnc:2730",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.725052757762299,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "BCL2L11",
                                "longName": "BCL2 like 11",
                                "conceptId": "hgnc:994",
                                "geneCategories": [
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.5437895683217243,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Augis V et al., 2013, A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib., PLoS One",
                                            "pmid": 24223824
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Indication",
                                    "value": "acute myeloid leukemia"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "resistant"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "FLT3",
                                "longName": "fms related receptor tyrosine kinase 3",
                                "conceptId": "hgnc:3765",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    }
                                ]
                            },
                            "interactionScore": 0.008735575394726493,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Kindler T et al., 2005, Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)., Blood",
                                            "pmid": 15345593
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "FGF2",
                                "longName": "fibroblast growth factor 2",
                                "conceptId": "hgnc:3676",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "GROWTH FACTOR"
                                    },
                                    {
                                        "name": "TUMOR SUPPRESSOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.04028070876457217,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Gilbert RE et al., 2001, PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis., Kidney Int",
                                            "pmid": 11260393
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "SLC2A4",
                                "longName": "solute carrier family 2 member 4",
                                "conceptId": "hgnc:11009",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    },
                                    {
                                        "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"
                                    }
                                ]
                            },
                            "interactionScore": 0.02230931562345535,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Tarn C et al., 2006, Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms., Cancer Res",
                                            "pmid": 16707477
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CYP2F1",
                                "longName": "cytochrome P450 family 2 subfamily F member 1",
                                "conceptId": "hgnc:2632",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CYTOCHROME P450"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.725052757762299,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ravegnini G et al., 2019, An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor., Pharmacogenomics J",
                                            "pmid": 30237583
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABCA3",
                                "longName": "ATP binding cassette subfamily A member 3",
                                "conceptId": "hgnc:33",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    },
                                    {
                                        "name": "ABC TRANSPORTER"
                                    }
                                ]
                            },
                            "interactionScore": 0.0149495413971608,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "de Lima LT et al., 2015, Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients., Hematology",
                                            "pmid": 25056761
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "HGF",
                                "longName": "hepatocyte growth factor",
                                "conceptId": "hgnc:4893",
                                "geneCategories": [
                                    {
                                        "name": "PROTEASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "GROWTH FACTOR"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.05577328905863839,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Frasca F et al., 2001, Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor., Oncogene",
                                            "pmid": 11439348
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Inhibition"
                                },
                                {
                                    "name": "Endogenous Drug",
                                    "value": "false"
                                },
                                {
                                    "name": "Direct Interaction",
                                    "value": "false"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "DUSP2",
                                "longName": "dual specificity phosphatase 2",
                                "conceptId": "hgnc:3068",
                                "geneCategories": [
                                    {
                                        "name": "PROTEIN PHOSPHATASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.08056141752914434,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "GuideToPharmacology"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "RAD52",
                                "longName": "RAD52 homolog, DNA repair protein",
                                "conceptId": "hgnc:9824",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.00823923588366249,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "KRAS:G12."
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "KRAS",
                                "longName": "KRAS proto-oncogene, GTPase",
                                "conceptId": "hgnc:6407",
                                "geneCategories": [
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    }
                                ]
                            },
                            "interactionScore": 0.007552632893357281,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "BIRC5",
                                "longName": "baculoviral IAP repeat containing 5",
                                "conceptId": "hgnc:593",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "PROTEASE INHIBITOR"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    }
                                ]
                            },
                            "interactionScore": 0.01647847176732498,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Carter BZ et al., 2006, Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells., Blood",
                                            "pmid": 16254145
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "PDGFB__COL1A1"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PDGFB",
                                "longName": "platelet derived growth factor subunit B",
                                "conceptId": "hgnc:8800",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "GROWTH FACTOR"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.4350316546573794,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "OncoKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ALK",
                                "longName": "ALK receptor tyrosine kinase",
                                "conceptId": "hgnc:427",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.01306401365337475,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Gunby RH et al., 2006, Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling., J Med Chem",
                                            "pmid": 16970400
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Combination Therapy",
                                    "value": "Trametinib;Imatinib"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "PRKCH:amp;ABL1__BCR"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PRKCH",
                                "longName": "protein kinase C eta",
                                "conceptId": "hgnc:9403",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.06042106314685825,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Inhibition"
                                },
                                {
                                    "name": "Endogenous Drug",
                                    "value": "false"
                                },
                                {
                                    "name": "Direct Interaction",
                                    "value": "false"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "DUSP1",
                                "longName": "dual specificity phosphatase 1",
                                "conceptId": "hgnc:3064",
                                "geneCategories": [
                                    {
                                        "name": "PROTEIN PHOSPHATASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.0483368505174866,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "GuideToPharmacology"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABCC4",
                                "longName": "ATP binding cassette subfamily C member 4 (PEL blood group)",
                                "conceptId": "hgnc:55",
                                "geneCategories": [
                                    {
                                        "name": "ABC TRANSPORTER"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    }
                                ]
                            },
                            "interactionScore": 0.04677759727498704,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Angelini S et al., 2013, Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy., Pharmacol Res",
                                            "pmid": 23127916
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "YES1",
                                "longName": "YES proto-oncogene 1, Src family tyrosine kinase",
                                "conceptId": "hgnc:12841",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.003485830566164899,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABI1",
                                "longName": "abl interactor 1",
                                "conceptId": "hgnc:11320",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.1812631894405747,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "EYA2",
                                "longName": "EYA transcriptional coactivator and phosphatase 2",
                                "conceptId": "hgnc:3520",
                                "geneCategories": [
                                    {
                                        "name": "DNA REPAIR"
                                    }
                                ]
                            },
                            "interactionScore": 0.02338879863749352,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "RET",
                                "longName": "ret proto-oncogene",
                                "conceptId": "hgnc:9967",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.03536842720791702,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Cohen MS et al., 2002, Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors., Surgery",
                                            "pmid": 12490842
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "MAPK10",
                                "longName": "mitogen-activated protein kinase 10",
                                "conceptId": "hgnc:6872",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.01859109635287946,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Fusion Protein",
                                    "value": "FIP1L1:PDGFRA"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "FIP1L1",
                                "longName": "factor interacting with PAPOLA and CPSF1",
                                "conceptId": "hgnc:19124",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.725052757762299,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ehmann F et al., 2014, European Medicines Agency initiatives and perspectives on pharmacogenomics., Br J Clin Pharmacol",
                                            "pmid": 24433361
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "FDA"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Indication",
                                    "value": "hematologic cancer"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "no benefit"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Cell culture"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CSF3R",
                                "longName": "colony stimulating factor 3 receptor",
                                "conceptId": "hgnc:2439",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"
                                    }
                                ]
                            },
                            "interactionScore": 0.05370761168609622,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Zhang H et al., 2018, Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation., J Biol Chem",
                                            "pmid": 29572350
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "IDH1",
                                "longName": "isocitrate dehydrogenase (NADP(+)) 1",
                                "conceptId": "hgnc:5382",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.001759836790685191,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ULK3",
                                "longName": "unc-51 like kinase 3",
                                "conceptId": "hgnc:19703",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.725052757762299,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Dressman MA et al., 2004, Correlation of major cytogenetic response with a pharmacogenetic marker in chronic myeloid leukemia patients treated with imatinib (STI571)., Clin Cancer Res",
                                            "pmid": 15073101
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABCB4",
                                "longName": "ATP binding cassette subfamily B member 4",
                                "conceptId": "hgnc:45",
                                "geneCategories": [
                                    {
                                        "name": "TRANSPORTER"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ABC TRANSPORTER"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.2900211031049196,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ravegnini G et al., 2019, An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor., Pharmacogenomics J",
                                            "pmid": 30237583
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "NF2:."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "NF2:del"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "NF2",
                                "longName": "NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",
                                "conceptId": "hgnc:7773",
                                "geneCategories": [
                                    {
                                        "name": "TUMOR SUPPRESSOR"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.1812631894405747,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Mukherjee J et al., 2009, Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate)., Cancer Res",
                                            "pmid": 19509233
                                        },
                                        {
                                            "citation": "Rackemann S et al., 1990, Uncemented press-fit total knee arthroplasty., J Arthroplasty",
                                            "pmid": 2290085
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "LYN",
                                "longName": "LYN proto-oncogene, Src family tyrosine kinase",
                                "conceptId": "hgnc:6735",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.01812631894405747,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABCG2",
                                "longName": "ATP binding cassette subfamily G member 2 (JR blood group)",
                                "conceptId": "hgnc:74",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    },
                                    {
                                        "name": "ABC TRANSPORTER"
                                    }
                                ]
                            },
                            "interactionScore": 0.03398684802010777,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Breedveld P et al., 2005, The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients., Cancer Res",
                                            "pmid": 15805252
                                        },
                                        {
                                            "citation": "Ozvegy-Laczka C et al., 2004, High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter., Mol Pharmacol",
                                            "pmid": 15155841
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Breedveld P et al., 2005, The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients., Cancer Res",
                                            "pmid": 15805252
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Breedveld P et al., 2005, The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients., Cancer Res",
                                            "pmid": 15805252
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Indication",
                                    "value": "myeloid leukemia"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "resistant"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Cell culture"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "JAK2",
                                "longName": "Janus kinase 2",
                                "conceptId": "hgnc:6192",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    }
                                ]
                            },
                            "interactionScore": 0.01479699505637345,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Elling C et al., 2011, Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease., Blood",
                                            "pmid": 21224473
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "LCK",
                                "longName": "LCK proto-oncogene, Src family tyrosine kinase",
                                "conceptId": "hgnc:6524",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.01421672074043723,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "RUNDC3B",
                                "longName": "RUN domain containing 3B",
                                "conceptId": "hgnc:30286",
                                "geneCategories": [

                                ]
                            },
                            "interactionScore": 1.450105515524598,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Verboom MC et al., 2019, Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors., Pharmacogenomics J",
                                            "pmid": 30713339
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "GSTT1",
                                "longName": "glutathione S-transferase theta 1",
                                "conceptId": "hgnc:4641",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    }
                                ]
                            },
                            "interactionScore": 0.1115465781172767,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Davies A et al., 2014, Dual glutathione-S-transferase-θ1 and -μ1 gene deletions determine imatinib failure in chronic myeloid leukemia., Clin Pharmacol Ther",
                                            "pmid": 25188725
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "HCK",
                                "longName": "HCK proto-oncogene, Src family tyrosine kinase",
                                "conceptId": "hgnc:4840",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.06905264359640943,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Donato NJ et al., 2003, BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571., Blood",
                                            "pmid": 12509383
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CHST1",
                                "longName": "carbohydrate sulfotransferase 1",
                                "conceptId": "hgnc:1969",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 1.450105515524598,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ravegnini G et al., 2019, An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor., Pharmacogenomics J",
                                            "pmid": 30237583
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "TAOK1",
                                "longName": "TAO kinase 1",
                                "conceptId": "hgnc:29259",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "DNA REPAIR"
                                    }
                                ]
                            },
                            "interactionScore": 0.02338879863749352,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Indication",
                                    "value": "gastrointestinal stromal tumor"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "resistant"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Pdx"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + LY294002"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "sensitive"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PTEN",
                                "longName": "phosphatase and tensin homolog",
                                "conceptId": "hgnc:9588",
                                "geneCategories": [
                                    {
                                        "name": "PTEN FAMILY"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "PROTEIN PHOSPHATASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.009603347784931113,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Na YS et al., 2017, Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors., Oncotarget",
                                            "pmid": 29100343
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "SMAD3",
                                "longName": "SMAD family member 3",
                                "conceptId": "hgnc:6769",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR COMPLEX"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.003166169247870301,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PVT1",
                                "longName": "Pvt1 oncogene",
                                "conceptId": "hgnc:9709",
                                "geneCategories": [

                                ]
                            },
                            "interactionScore": 0.725052757762299,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Zhelev Z et al., 2004, Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study)., FEBS Lett",
                                            "pmid": 15251464
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "SLCO1A2",
                                "longName": "solute carrier organic anion transporter family member 1A2",
                                "conceptId": "hgnc:10956",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    }
                                ]
                            },
                            "interactionScore": 0.1812631894405747,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Yamakawa Y et al., 2011, Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia., Clin Pharmacol Ther",
                                            "pmid": 21633340
                                        },
                                        {
                                            "citation": "Maekawa K et al., 2022, Impacts of SNPs on adverse events and trough concentration of imatinib in patients with gastrointestinal stromal tumors., Drug Metab Pharmacokinet",
                                            "pmid": 35144161
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "IRAK1",
                                "longName": "interleukin 1 receptor associated kinase 1",
                                "conceptId": "hgnc:6112",
                                "geneCategories": [
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.03816067146117363,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CYP3A4",
                                "longName": "cytochrome P450 family 3 subfamily A member 4",
                                "conceptId": "hgnc:2637",
                                "geneCategories": [
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "CYTOCHROME P450"
                                    }
                                ]
                            },
                            "interactionScore": 0.001622041963674046,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "van Erp NP et al., 2007, Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib., Clin Cancer Res",
                                            "pmid": 18094422
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "EGFR",
                                "longName": "epidermal growth factor receptor",
                                "conceptId": "hgnc:3236",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    }
                                ]
                            },
                            "interactionScore": 0.007552632893357281,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Qiu HB et al., 2018, Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1., Pharmacogenomics J",
                                            "pmid": 28762371
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "IKZF1",
                                "longName": "IKAROS family zinc finger 1",
                                "conceptId": "hgnc:13176",
                                "geneCategories": [
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.1450105515524598,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "preclinical"
                                },
                                {
                                    "name": "Pathway",
                                    "value": "activation"
                                },
                                {
                                    "name": "Variant Effect",
                                    "value": "gain-of-function"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "CSF1R:Y571D"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CSF1R",
                                "longName": "colony stimulating factor 1 receptor",
                                "conceptId": "hgnc:2433",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    }
                                ]
                            },
                            "interactionScore": 0.08056141752914434,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Chase A et al., 2009, Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1., Leukemia",
                                            "pmid": 18971950
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DoCM"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "SFN",
                                "longName": "stratifin",
                                "conceptId": "hgnc:10773",
                                "geneCategories": [
                                    {
                                        "name": "TUMOR SUPPRESSOR"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    }
                                ]
                            },
                            "interactionScore": 1.450105515524598,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Corradi V et al., 2011, Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case., Bioorg Med Chem Lett",
                                            "pmid": 21962576
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "CD40LG",
                                "longName": "CD40 ligand",
                                "conceptId": "hgnc:11935",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    }
                                ]
                            },
                            "interactionScore": 0.05000363846636545,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Dicker F et al., 2006, CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53., Blood",
                                            "pmid": 16741250
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ARID5B",
                                "longName": "AT-rich interaction domain 5B",
                                "conceptId": "hgnc:17362",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    }
                                ]
                            },
                            "interactionScore": 0.483368505174866,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Cereja Pantoja KBC et al., 2022, Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia., Genes (Basel)",
                                            "pmid": 35205374
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "ABCB1",
                                "longName": "ATP binding cassette subfamily B member 1",
                                "conceptId": "hgnc:40",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "ABC TRANSPORTER"
                                    },
                                    {
                                        "name": "TRANSPORTER"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CELL SURFACE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.009255992652284668,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Ozvegy-Laczka C et al., 2004, High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter., Mol Pharmacol",
                                            "pmid": 15155841
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Breedveld P et al., 2005, The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients., Cancer Res",
                                            "pmid": 15805252
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + PLX4720"
                                },
                                {
                                    "name": "Indication",
                                    "value": "melanoma"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "sensitive"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Cell line xenograft"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "BRAF",
                                "longName": "B-Raf proto-oncogene, serine/threonine kinase",
                                "conceptId": "hgnc:1097",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.007250527577622991,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Vinik A et al., 2016, Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial., Target Oncol",
                                            "pmid": 27924459
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [
                                {
                                    "name": "Alteration",
                                    "value": "KIT::consequence::inframe_deletion:416-422,::inframe_insertion:416-422"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT::consequence::inframe_deletion:V560."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:449-514,550-592,627-664,664-714,788-828"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:550-592,627-664"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:D820Y"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:Y553N"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT::wildtype:."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:627-664,664-714,449-514"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:788-828"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:788-828,829-860"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:amp"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:D816."
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:T670I"
                                },
                                {
                                    "name": "Alteration",
                                    "value": "KIT:V559I,H697Y,T670.,V654A,A829P,D816.,N822.,Y823D"
                                },
                                {
                                    "name": "Clinical Trial Name",
                                    "value": "imatinib mesylate, STI 571,Gleevec, Glivec"
                                },
                                {
                                    "name": "Novel Drug Target",
                                    "value": "Established target"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "no benefit"
                                },
                                {
                                    "name": "Indication",
                                    "value": "prostate neuroendocrine neoplasm"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical"
                                },
                                {
                                    "name": "Evidence Type",
                                    "value": "Actionable"
                                },
                                {
                                    "name": "Indication",
                                    "value": "germ cell cancer"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Phase II"
                                },
                                {
                                    "name": "Indication",
                                    "value": "gastrointestinal stromal tumor"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "sensitive"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "FDA approved"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + Letrozole"
                                },
                                {
                                    "name": "Indication",
                                    "value": "breast cancer"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "predicted - sensitive"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Phase 0"
                                },
                                {
                                    "name": "Indication",
                                    "value": "seminoma"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Case Reports/Case Series"
                                },
                                {
                                    "name": "Indication",
                                    "value": "thymic carcinoma"
                                },
                                {
                                    "name": "Indication",
                                    "value": "chronic leukemia"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Phase I"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + Infigratinib"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Pdx"
                                },
                                {
                                    "name": "Indication",
                                    "value": "extraskeletal myxoid chondrosarcoma"
                                },
                                {
                                    "name": "Indication",
                                    "value": "Advanced Solid Tumor"
                                },
                                {
                                    "name": "Indication",
                                    "value": "melanoma"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "predicted - resistant"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Cell culture"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "resistant"
                                },
                                {
                                    "name": "Indication",
                                    "value": "systemic mastocytosis"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "FDA contraindicated"
                                },
                                {
                                    "name": "Indication",
                                    "value": "hematologic cancer"
                                },
                                {
                                    "name": "Indication",
                                    "value": "mast cell neoplasm"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "decreased response"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Cell line xenograft"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + Pembrolizumab"
                                },
                                {
                                    "name": "Indication",
                                    "value": "acute myeloid leukemia"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Binimetinib + Imatinib"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + MK2206"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Copanlisib + Imatinib"
                                },
                                {
                                    "name": "Indication",
                                    "value": "vulvar melanoma"
                                },
                                {
                                    "name": "Indication",
                                    "value": "skin melanoma"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Guideline"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "unknown"
                                },
                                {
                                    "name": "Indication",
                                    "value": "mastocytosis"
                                },
                                {
                                    "name": "Indication",
                                    "value": "mucosal melanoma"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + LY294002"
                                },
                                {
                                    "name": "Indication",
                                    "value": "gastric adenocarcinoma"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "G007-LK + Imatinib"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Pdx & cell culture"
                                },
                                {
                                    "name": "Response Type",
                                    "value": "conflicting"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Phase III"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + XAV939"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + PKF118-310"
                                },
                                {
                                    "name": "Combination Therapy",
                                    "value": "Imatinib + Spartalizumab"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Phase Ib/II"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "Preclinical - Biochemical"
                                },
                                {
                                    "name": "Clinical Trial ID",
                                    "value": "NCT01738139"
                                },
                                {
                                    "name": "Cancer Type",
                                    "value": "Thymic Carcinoma"
                                },
                                {
                                    "name": "Indication",
                                    "value": "Official title: Imatinib Mesylate (c-Kit Inhibitor)."
                                },
                                {
                                    "name": "Direct Interaction",
                                    "value": "true"
                                },
                                {
                                    "name": "Mechanism of Action",
                                    "value": "Stem cell growth factor receptor inhibitor"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "case report"
                                },
                                {
                                    "name": "Approval Status",
                                    "value": "preclinical"
                                },
                                {
                                    "name": "Pathway",
                                    "value": "activation"
                                },
                                {
                                    "name": "Variant Effect",
                                    "value": "gain-of-function"
                                }
                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "KIT",
                                "longName": "KIT proto-oncogene, receptor tyrosine kinase",
                                "conceptId": "hgnc:6342",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "EXTERNAL SIDE OF PLASMA MEMBRANE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    }
                                ]
                            },
                            "interactionScore": 1.049193990644268,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Todd JR et al., 2013, Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells., Pigment Cell Melanoma Res",
                                            "pmid": 23582185
                                        },
                                        {
                                            "citation": "Carvajal RD et al., 2011, KIT as a therapeutic target in metastatic melanoma., JAMA",
                                            "pmid": 21642685
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2008, Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor., J Clin Oncol",
                                            "pmid": 18955458
                                        },
                                        {
                                            "citation": "Wasag B et al., 2011, Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis., Exp Hematol",
                                            "pmid": 21689725
                                        },
                                        {
                                            "citation": "Guo J et al., 2011, Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification., J Clin Oncol",
                                            "pmid": 21690468
                                        },
                                        {
                                            "citation": "Nakagomi N et al., 2007, Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation., Lab Invest",
                                            "pmid": 17259998
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2008, Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group., J Clin Oncol",
                                            "pmid": 18955451
                                        },
                                        {
                                            "citation": "Debiec-Rychter M et al., 2006, KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours., Eur J Cancer",
                                            "pmid": 16624552
                                        },
                                        {
                                            "citation": "Minor DR et al., 2012, Sunitinib therapy for melanoma patients with KIT mutations., Clin Cancer Res",
                                            "pmid": 22261812
                                        },
                                        {
                                            "citation": "Hodi FS et al., 2008, Major response to imatinib mesylate in KIT-mutated melanoma., J Clin Oncol",
                                            "pmid": 18421059
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CGI"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "ChEMBL"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "COSMIC"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Tamborini E et al., 2006, Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients., Oncogene",
                                            "pmid": 16751810
                                        },
                                        {
                                            "citation": "McDonnell K et al., 2011, V559A and N822I double KIT mutant melanoma with predictable response to imatinib?, Pigment Cell Melanoma Res",
                                            "pmid": 21159146
                                        },
                                        {
                                            "citation": "Ustun C et al., 2009, Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V., Leuk Res",
                                            "pmid": 18986703
                                        },
                                        {
                                            "citation": "Hodi FS et al., 2013, Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin., J Clin Oncol",
                                            "pmid": 23775962
                                        },
                                        {
                                            "citation": "Tornillo L et al., 2006, An update on molecular genetics of gastrointestinal stromal tumours., J Clin Pathol",
                                            "pmid": 16731599
                                        },
                                        {
                                            "citation": "Kitayama H et al., 1995, Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines., Blood",
                                            "pmid": 7530509
                                        },
                                        {
                                            "citation": "Pan J et al., 2007, EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation., Blood",
                                            "pmid": 16912224
                                        },
                                        {
                                            "citation": "Todd JR et al., 2013, Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells., Pigment Cell Melanoma Res",
                                            "pmid": 23582185
                                        },
                                        {
                                            "citation": "Carvajal RD et al., 2011, KIT as a therapeutic target in metastatic melanoma., JAMA",
                                            "pmid": 21642685
                                        },
                                        {
                                            "citation": "Cairoli R et al., 2006, Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study., Blood",
                                            "pmid": 16384925
                                        },
                                        {
                                            "citation": "Terheyden P et al., 2010, Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene., J Invest Dermatol",
                                            "pmid": 19812602
                                        },
                                        {
                                            "citation": "Smith CC et al., 2012, Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia., Nature",
                                            "pmid": 22504184
                                        },
                                        {
                                            "citation": "Wasag B et al., 2011, Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis., Exp Hematol",
                                            "pmid": 21689725
                                        },
                                        {
                                            "citation": "Woodman SE et al., 2009, Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates., Mol Cancer Ther",
                                            "pmid": 19671763
                                        },
                                        {
                                            "citation": "Quintás-Cardama A et al., 2008, Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib., Nat Clin Pract Oncol",
                                            "pmid": 18936790
                                        },
                                        {
                                            "citation": "Guo J et al., 2011, Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification., J Clin Oncol",
                                            "pmid": 21690468
                                        },
                                        {
                                            "citation": "Prenen H et al., 2006, Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate., Clin Cancer Res",
                                            "pmid": 16638875
                                        },
                                        {
                                            "citation": "Hong JL et al., 2012, [Secondary mutation of c-kit/PDGFRα genotypes after imatinib mesylate therapy and its relationship with efficacy of sunitinib]., Zhonghua Bing Li Xue Za Zhi",
                                            "pmid": 22932406
                                        },
                                        {
                                            "citation": "Girard N et al., 2009, Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas., Clin Cancer Res",
                                            "pmid": 19861435
                                        },
                                        {
                                            "citation": "Nakagomi N et al., 2007, Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation., Lab Invest",
                                            "pmid": 17259998
                                        },
                                        {
                                            "citation": "Gleixner KV et al., 2007, Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT., Haematologica",
                                            "pmid": 18024392
                                        },
                                        {
                                            "citation": "Beadling C et al., 2008, KIT gene mutations and copy number in melanoma subtypes., Clin Cancer Res",
                                            "pmid": 18980976
                                        },
                                        {
                                            "citation": "Handolias D et al., 2010, Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure., Pigment Cell Melanoma Res",
                                            "pmid": 20088873
                                        },
                                        {
                                            "citation": "Growney JD et al., 2005, Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412., Blood",
                                            "pmid": 15790786
                                        },
                                        {
                                            "citation": "Johnson RC et al., 2013, Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22)., Am J Clin Pathol",
                                            "pmid": 24045550
                                        },
                                        {
                                            "citation": "Antonescu CR et al., 2007, L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition., Int J Cancer",
                                            "pmid": 17372901
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2006, Molecular correlates of imatinib resistance in gastrointestinal stromal tumors., J Clin Oncol",
                                            "pmid": 16954519
                                        },
                                        {
                                            "citation": "Smith CC et al., 2013, The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia., Am Soc Clin Oncol Educ Book",
                                            "pmid": 23714533
                                        },
                                        {
                                            "citation": "Hirota S et al., 2001, Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours., J Pathol",
                                            "pmid": 11276010
                                        },
                                        {
                                            "citation": "Buti S et al., 2011, Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma., J Clin Oncol",
                                            "pmid": 21969494
                                        },
                                        {
                                            "citation": "Schirosi L et al., 2012, Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors., Ann Oncol",
                                            "pmid": 22357254
                                        },
                                        {
                                            "citation": "Curtin JA et al., 2006, Somatic activation of KIT in distinct subtypes of melanoma., J Clin Oncol",
                                            "pmid": 16908931
                                        },
                                        {
                                            "citation": "Carter TA et al., 2005, Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases., Proc Natl Acad Sci U S A",
                                            "pmid": 16046538
                                        },
                                        {
                                            "citation": "Tefferi A, 2009, Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1., J Cell Mol Med",
                                            "pmid": 19175693
                                        },
                                        {
                                            "citation": "Hirota S et al., 1998, Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors., Science",
                                            "pmid": 9438854
                                        },
                                        {
                                            "citation": "Gajiwala KS et al., 2009, KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients., Proc Natl Acad Sci U S A",
                                            "pmid": 19164557
                                        },
                                        {
                                            "citation": "Roberts KG et al., 2007, Resistance to c-KIT kinase inhibitors conferred by V654A mutation., Mol Cancer Ther",
                                            "pmid": 17363509
                                        },
                                        {
                                            "citation": "Antonescu CR et al., 2005, Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation., Clin Cancer Res",
                                            "pmid": 15930355
                                        },
                                        {
                                            "citation": "Tutone M et al., 2011, Study of the role of \"gatekeeper\" mutations V654A and T670I of c-kit kinase in the interaction with inhibitors by means mixed molecular dynamics/docking approach., Bioinformation",
                                            "pmid": 22355224
                                        },
                                        {
                                            "citation": "Rossi V et al., 2013, When a thymic carcinoma \"becomes\" a GIST., Lung Cancer",
                                            "pmid": 23375402
                                        },
                                        {
                                            "citation": "Tamborini E et al., 2004, A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient., Gastroenterology",
                                            "pmid": 15236194
                                        },
                                        {
                                            "citation": "Serrano C et al., 2015, KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation., J Clin Oncol",
                                            "pmid": 24687822
                                        },
                                        {
                                            "citation": "MacConaill LE et al., 2014, Prospective enterprise-level molecular genotyping of a cohort of cancer patients., J Mol Diagn",
                                            "pmid": 25157968
                                        },
                                        {
                                            "citation": "Debiec-Rychter M et al., 2005, Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants., Gastroenterology",
                                            "pmid": 15685537
                                        },
                                        {
                                            "citation": "Ströbel P et al., 2004, Thymic carcinoma with overexpression of mutated KIT and the response to imatinib., N Engl J Med",
                                            "pmid": 15201427
                                        },
                                        {
                                            "citation": "Gotlib J et al., 2005, Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation., Blood",
                                            "pmid": 15972446
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "DoCM"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "FDA"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "MyCancerGenome"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "MyCancerGenomeClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Tuveson DA et al., 2001, STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications., Oncogene",
                                            "pmid": 11526490
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "PharmGKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TALC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TdgClinicalTrial"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TEND"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TTD"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "CIViC"
                                    }
                                },
                                {
                                    "publications": [
                                        {
                                            "citation": "Joensuu H et al., 2023, KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial., Clin Cancer Res",
                                            "pmid": 37014660
                                        },
                                        {
                                            "citation": "Kelly CM et al., 2019, A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor., Invest New Drugs",
                                            "pmid": 30101387
                                        },
                                        {
                                            "citation": "Tamborini E et al., 2006, Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients., Oncogene",
                                            "pmid": 16751810
                                        },
                                        {
                                            "citation": "García-Valverde A et al., 2020, Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor., Mol Cancer Ther",
                                            "pmid": 32371592
                                        },
                                        {
                                            "citation": "Zhang LY et al., 2006, A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy., Leuk Res",
                                            "pmid": 16183119
                                        },
                                        {
                                            "citation": "Zeng S et al., 2017, Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor., Mol Cancer Ther",
                                            "pmid": 28611108
                                        },
                                        {
                                            "citation": "Todd JR et al., 2013, Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells., Pigment Cell Melanoma Res",
                                            "pmid": 23582185
                                        },
                                        {
                                            "citation": "Allegra M et al., 2014, A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib., J Invest Dermatol",
                                            "pmid": 24317392
                                        },
                                        {
                                            "citation": "Goemans BF et al., 2005, Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia., Leukemia",
                                            "pmid": 16015387
                                        },
                                        {
                                            "citation": "Makris EA et al., 2021, Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations., JCO Precis Oncol",
                                            "pmid": 34250403
                                        },
                                        {
                                            "citation": "Terheyden P et al., 2010, Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene., J Invest Dermatol",
                                            "pmid": 19812602
                                        },
                                        {
                                            "citation": "Li F et al., 2015, FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors., Cancer Discov",
                                            "pmid": 25673643
                                        },
                                        {
                                            "citation": "Hoffmann KM et al., 2008, Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation., Blood",
                                            "pmid": 18567837
                                        },
                                        {
                                            "citation": "Hagemann IS et al., 2014, Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing., J Thorac Oncol",
                                            "pmid": 24419427
                                        },
                                        {
                                            "citation": "Jennings B et al., 2021, Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel KIT mutation., BMJ Case Rep",
                                            "pmid": 34446510
                                        },
                                        {
                                            "citation": "Iida K et al., 2021, Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug Conjugate., Cancer Discov",
                                            "pmid": 33579785
                                        },
                                        {
                                            "citation": "Chi P et al., 2022, Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor., J Clin Oncol",
                                            "pmid": 35041493
                                        },
                                        {
                                            "citation": "Lim KH et al., 2008, Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors., Med Oncol",
                                            "pmid": 18488160
                                        },
                                        {
                                            "citation": "Wasag B et al., 2011, Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis., Exp Hematol",
                                            "pmid": 21689725
                                        },
                                        {
                                            "citation": "Einhorn LH et al., 2006, Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT., Am J Clin Oncol",
                                            "pmid": 16462496
                                        },
                                        {
                                            "citation": "Ninomiya K et al., 2024, Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report., JCO Precis Oncol",
                                            "pmid": 39298692
                                        },
                                        {
                                            "citation": "Speight RA et al., 2013, Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis., J Clin Oncol",
                                            "pmid": 23610110
                                        },
                                        {
                                            "citation": "Fornasarig M et al., 2020, A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity., J Pers Med",
                                            "pmid": 33212994
                                        },
                                        {
                                            "citation": "Zook P et al., 2017, Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor., Clin Cancer Res",
                                            "pmid": 27370604
                                        },
                                        {
                                            "citation": "Mussi C et al., 2008, Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1., Clin Cancer Res",
                                            "pmid": 18628470
                                        },
                                        {
                                            "citation": "Carlino MS et al., 2014, Resistance to c-Kit inhibitors in melanoma: insights for future therapies., Oncoscience",
                                            "pmid": 25594040
                                        },
                                        {
                                            "citation": "Iurlo A et al., 2014, Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response., Oncotarget",
                                            "pmid": 25015329
                                        },
                                        {
                                            "citation": "Girard N et al., 2009, Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas., Clin Cancer Res",
                                            "pmid": 19861435
                                        },
                                        {
                                            "citation": "Jachetti E et al., 2017, Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β., Mol Cancer Ther",
                                            "pmid": 27980106
                                        },
                                        {
                                            "citation": "Nishida T et al., 2008, Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor., Cancer Sci",
                                            "pmid": 18294292
                                        },
                                        {
                                            "citation": "Zhao J et al., 2014, Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants., Cancer Sci",
                                            "pmid": 24205792
                                        },
                                        {
                                            "citation": "Frost MJ et al., 2002, Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant., Mol Cancer Ther",
                                            "pmid": 12481435
                                        },
                                        {
                                            "citation": "Dagher R et al., 2002, Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors., Clin Cancer Res",
                                            "pmid": 12374669
                                        },
                                        {
                                            "citation": "Gebreyohannes YK et al., 2016, Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations., Mol Cancer Ther",
                                            "pmid": 27777285
                                        },
                                        {
                                            "citation": "Conca E et al., 2013, Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib., Mol Oncol",
                                            "pmid": 23567324
                                        },
                                        {
                                            "citation": "Spitaleri G et al., 2015, Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)., Onco Targets Ther",
                                            "pmid": 26316776
                                        },
                                        {
                                            "citation": "Hartmann K et al., 2005, Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis., Gastroenterology",
                                            "pmid": 16143141
                                        },
                                        {
                                            "citation": "Pectasides D et al., 2008, Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma., Anticancer Res",
                                            "pmid": 18751412
                                        },
                                        {
                                            "citation": "Growney JD et al., 2005, Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412., Blood",
                                            "pmid": 15790786
                                        },
                                        {
                                            "citation": "Banks E et al., 2020, Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors., Sci Transl Med",
                                            "pmid": 32350132
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2017, Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033., JAMA Oncol",
                                            "pmid": 28196207
                                        },
                                        {
                                            "citation": "Ran L et al., 2015, Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth., Cancer Discov",
                                            "pmid": 25572173
                                        },
                                        {
                                            "citation": "Heinrich MC et al., 2006, Molecular correlates of imatinib resistance in gastrointestinal stromal tumors., J Clin Oncol",
                                            "pmid": 16954519
                                        },
                                        {
                                            "citation": "Buti S et al., 2011, Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma., J Clin Oncol",
                                            "pmid": 21969494
                                        },
                                        {
                                            "citation": "Joensuu H et al., 2017, Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial., JAMA Oncol",
                                            "pmid": 28334365
                                        },
                                        {
                                            "citation": "de Melo Campos P et al., 2014, Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412., Leuk Res",
                                            "pmid": 25139846
                                        },
                                        {
                                            "citation": "Casali PG et al., 2022, Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up., Ann Oncol",
                                            "pmid": 34560242
                                        },
                                        {
                                            "citation": "Rapisuwon S et al., 2014, Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report., Melanoma Res",
                                            "pmid": 25003536
                                        },
                                        {
                                            "citation": "Gebreyohannes YK et al., 2019, PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors., Clin Exp Med",
                                            "pmid": 30523507
                                        },
                                        {
                                            "citation": "Schöffski P et al., 2022, In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor., Biomedicines",
                                            "pmid": 35625872
                                        },
                                        {
                                            "citation": "Abdou Y et al., 2019, Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report., Medicine (Baltimore)",
                                            "pmid": 31689840
                                        },
                                        {
                                            "citation": "Orlova KV et al., 2019, Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I., Case Rep Oncol",
                                            "pmid": 31043947
                                        },
                                        {
                                            "citation": "Kim HD et al., 2024, Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 Plus Imatinib for Advanced Treatment-Refractory Gastrointestinal Stromal Tumors., Clin Cancer Res",
                                            "pmid": 38662455
                                        },
                                        {
                                            "citation": "Smith BD et al., 2019, Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants., Cancer Cell",
                                            "pmid": 31085175
                                        },
                                        {
                                            "citation": "Tamborini E et al., 2004, A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient., Gastroenterology",
                                            "pmid": 15236194
                                        },
                                        {
                                            "citation": "Liu J et al., 2022, Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumours., Mol Oncol",
                                            "pmid": 35194937
                                        },
                                        {
                                            "citation": "Handolias D et al., 2010, Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT., Br J Cancer",
                                            "pmid": 20372153
                                        },
                                        {
                                            "citation": "Patrikidou A et al., 2016, Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group., Eur J Cancer",
                                            "pmid": 26687836
                                        },
                                        {
                                            "citation": "Na YS et al., 2017, Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors., Oncotarget",
                                            "pmid": 29100343
                                        },
                                        {
                                            "citation": "Akin C et al., 2004, A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib., Blood",
                                            "pmid": 15070706
                                        },
                                        {
                                            "citation": "Chow LW et al., 2008, Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer., Cancer Lett",
                                            "pmid": 18248884
                                        },
                                        {
                                            "citation": "Zhan Y et al., 2017, MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma., J Clin Invest",
                                            "pmid": 29035277
                                        },
                                        {
                                            "citation": "Foster R et al., 2008, Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT., Br J Dermatol",
                                            "pmid": 18795925
                                        },
                                        {
                                            "citation": "Schittenhelm MM et al., 2006, Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies., Cancer Res",
                                            "pmid": 16397263
                                        },
                                        {
                                            "citation": "Ströbel P et al., 2004, Thymic carcinoma with overexpression of mutated KIT and the response to imatinib., N Engl J Med",
                                            "pmid": 15201427
                                        },
                                        {
                                            "citation": "Garner AP et al., 2014, Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients., Clin Cancer Res",
                                            "pmid": 25239608
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "CKB-CORE"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "OncoKB"
                                    }
                                },
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TTD"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "PIK3CG",
                                "longName": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",
                                "conceptId": "hgnc:8978",
                                "geneCategories": [
                                    {
                                        "name": "PHOSPHATIDYLINOSITOL 3 KINASE"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    }
                                ]
                            },
                            "interactionScore": 0.01098564784488331,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Andreu EJ et al., 2005, BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells., Cancer Res",
                                            "pmid": 15833859
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "RUNX1",
                                "longName": "RUNX family transcription factor 1",
                                "conceptId": "hgnc:10471",
                                "geneCategories": [
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    }
                                ]
                            },
                            "interactionScore": 0.04143158615784565,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Wang YY et al., 2005, AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec., Proc Natl Acad Sci U S A",
                                            "pmid": 15650049
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "FRK",
                                "longName": "fyn related Src family tyrosine kinase",
                                "conceptId": "hgnc:3955",
                                "geneCategories": [
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "ENZYME"
                                    }
                                ]
                            },
                            "interactionScore": 0.02589474134865353,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "DTC"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "MYC",
                                "longName": "MYC proto-oncogene, bHLH transcription factor",
                                "conceptId": "hgnc:7553",
                                "geneCategories": [
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "TRANSCRIPTION FACTOR"
                                    }
                                ]
                            },
                            "interactionScore": 0.02071579307892282,
                            "interactionClaims": [
                                {
                                    "publications": [
                                        {
                                            "citation": "Kawano T et al., 2004, Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect., Anticancer Res",
                                            "pmid": 15517875
                                        }
                                    ],
                                    "source": {
                                        "sourceDbName": "NCI"
                                    }
                                }
                            ]
                        },
                        {
                            "interactionAttributes": [

                            ],
                            "drug": {
                                "name": "IMATINIB",
                                "conceptId": "rxcui:282388",
                                "approved": true
                            },
                            "gene": {
                                "name": "SYK",
                                "longName": "spleen associated tyrosine kinase",
                                "conceptId": "hgnc:11491",
                                "geneCategories": [
                                    {
                                        "name": "ENZYME"
                                    },
                                    {
                                        "name": "DRUG RESISTANCE"
                                    },
                                    {
                                        "name": "CLINICALLY ACTIONABLE"
                                    },
                                    {
                                        "name": "KINASE"
                                    },
                                    {
                                        "name": "TYROSINE KINASE"
                                    },
                                    {
                                        "name": "DRUGGABLE GENOME"
                                    },
                                    {
                                        "name": "SERINE THREONINE KINASE"
                                    }
                                ]
                            },
                            "interactionScore": 0.02071579307892282,
                            "interactionClaims": [
                                {
                                    "publications": [

                                    ],
                                    "source": {
                                        "sourceDbName": "TTD"
                                    }
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    }
}
